Article ; Online: Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
Current atherosclerosis reports
2010 Volume 13, Issue 1, Page(s) 51–56
Abstract: There is a significant prevalence (20%-80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatment-associated metabolic and ... ...
| Abstract | There is a significant prevalence (20%-80% depending on the population and the study) of lipid disorders and other cardiovascular risk factors in people living with HIV infection. This review focuses on HIV and HIV treatment-associated metabolic and cardiovascular concerns, including dyslipidemias, lipodystrophy syndromes, endothelial dysfunctions, and associated metabolic events such as insulin resistance. Emerging hypotheses of the underlying pathophysiology of these issues, with impact on selection of specific antiretroviral treatment (ART) strategies, therapy, and preventive approaches to decreasing cardiovascular risk and other problems associated with these syndromes are discussed. Screening for cardiovascular risk as part of the decision of starting antiretroviral therapy, and during care of patients with HIV regardless of ART therapy status, is suggested with particular areas of focus. Statins, other hyperlipidemic therapies, treatment for specific problems arising due to lipodystrophy, and implications on ART selection to avoid drug interactions and adverse effects are also discussed. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Anti-Retroviral Agents/pharmacology ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/prevention & control ; Drug Interactions ; Dyslipidemias/complications ; Dyslipidemias/drug therapy ; Dyslipidemias/metabolism ; Dyslipidemias/physiopathology ; Endothelium, Vascular/drug effects ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; HIV ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/metabolism ; HIV Infections/physiopathology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Insulin Resistance ; Lipid Metabolism/drug effects ; Lipodystrophy/complications ; Lipodystrophy/drug therapy ; Lipodystrophy/metabolism ; Lipodystrophy/physiopathology ; Long-Term Care ; Risk Factors ; Secondary Prevention | |||||
| Chemical Substances | Anti-Retroviral Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors | |||||
| Language | English | |||||
| Publishing date | 2010-12-22 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Review | |||||
| ZDB-ID | 2057369-8 | |||||
| ISSN | 1534-6242 ; 1523-3804 | |||||
| ISSN (online) | 1534-6242 | |||||
| ISSN | 1523-3804 | |||||
| DOI | 10.1007/s11883-010-0152-1 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5534: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.